Sponsored Research and Clinical Trial Agreements (Schedule of Research and Development for Sponsored Research and Clinical Trial Agreements) (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Research and development | $ 113,240 | $ 61,275 |
Research and Clinical Trial Agreements [Member] | ||
Research and development | 7,845 | 9,165 |
Research and Clinical Trial Agreements [Member] | Aevitas [Member] | ||
Research and development | 289 | 948 |
Research and Clinical Trial Agreements [Member] | Mustang [Member] | ||
Research and development | 6,591 | 7,717 |
Research and Clinical Trial Agreements [Member] | Oncogenuity [Member] | ||
Research and development | $ 965 | $ 500 |
X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|